Some Central and Peripheral Effects of Meclastine, a New Antihistaminic Drug, in Man
作者： Annmarie Hedges , M. Hills , William P. Maclay , A. J. Newman-Taylor , Paul Turner
DOI: 10.1177/009127007101100206
关键词:
摘要:
sci-hub.se 参考文章(5)
P. Turner, Critical flicker frequency and centrally-acting drugs. British Journal of Ophthalmology. ,vol. 52, pp. 245- 250 ,(1968) , 10.1136/BJO.52.3.245
Roncevich A, Allergic rhinitis and its control by antihistamines: clinical trial of Tavegyl (meclastine). Current Therapeutic Research-clinical and Experimental. ,vol. 11, pp. 625- 633 ,(1969)
L. Joubert, Z. Gaut, W. B. Abrams, A new approach to the use of histamine skin tests in the study of antihistamine drugs Clinical Pharmacology & Therapeutics. ,vol. 10, pp. 250- 257 ,(1969) , 10.1002/CPT1969102250
Morton Fj, Collins Is, Mecloprodin (Tavegyl)--a new antihistamine: clinical trials in Australia 1966-1967. Current Therapeutic Research-clinical and Experimental. ,vol. 10, pp. 373- 381 ,(1968)
Round Table Conference on Tavegyl® (HS 592) International Archives of Allergy and Immunology. ,vol. 31, pp. 607- 612 ,(1967) , 10.1159/000229907